Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | ProJenX | MAP4K ALS and Neurodegenerative Disease |
Description | A New Approach to Treating ProJenX’s mission is to make prosetin, a scientifically validated, first-in-class MAP4 kinase inhibitor, available for ALS and other neurodegenerative |
Keywords | N/A |
WebSite | projenx.com |
Host IP | 198.71.233.187 |
Location | United States |
Site | Rank |
US$1,762,480
Last updated: 2023-05-17 05:25:39
projenx.com has Semrush global rank of 6,005,349. projenx.com has an estimated worth of US$ 1,762,480, based on its estimated Ads revenue. projenx.com receives approximately 203,363 unique visitors each day. Its web server is located in United States, with IP address 198.71.233.187. According to SiteAdvisor, projenx.com is safe to visit. |
Purchase/Sale Value | US$1,762,480 |
Daily Ads Revenue | US$1,627 |
Monthly Ads Revenue | US$48,808 |
Yearly Ads Revenue | US$585,686 |
Daily Unique Visitors | 13,558 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
projenx.com. | A | 600 | IP: 198.71.233.187 |
projenx.com. | NS | 3600 | NS Record: ns57.domaincontrol.com. |
projenx.com. | NS | 3600 | NS Record: ns58.domaincontrol.com. |
projenx.com. | MX | 3600 | MX Record: 0 projenx-com.mail.protection.outlook.com. |
projenx.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
projenx.com. | TXT | 3600 | TXT Record: MS=ms43095523 |
Contact Us --> About Our Science News Contact Us About Our Science News Contact Us A New Approach to Treating ALS ProJenX is on a mission to make prosetin, a scientifically validated, first-in-class MAP4 kinase inhibitor, available to people with ALS. Contact Us About ProJenX ProJenX spun out of a long-term collaboration between the ALS research nonprofit, Project ALS, and researchers at Columbia University, who have worked together for over twenty years toward a shared goal of developing the first effective treatments, and ultimately a cure, for ALS. Learn More Prosetin: Changing the Trajectory of ALS Prosetin is the first brain-penetrant MAP4K inhibitor therapy to enter clinical trials. ProJenX scientific co-founders at Columbia University have shown that prosetin is highly effective across multiple laboratory models of ALS. See Our Science Penetrating the Blood-Brain Barrier Even though ALS is a brain disease, most drugs developed for ALS cannot cross the “blood-brain barrier” |
HTTP/1.1 301 Moved Permanently Age: 0 Content-Security-Policy: upgrade-insecure-requests Content-Type: text/html; charset=iso-8859-1 Date: Tue, 08 Mar 2022 08:36:09 GMT Location: https://projenx.com/ Vary: User-Agent, Accept-Encoding X-Backend: local X-Cache: uncached X-Cache-Hit: MISS X-Cacheable: NO:HTTPS Redirect X-Content-Type-Options: nosniff X-Xss-Protection: 1; mode=block HTTP/2 200 server: openresty date: Tue, 08 Mar 2022 08:36:09 GMT content-type: text/html; charset=UTF-8 content-length: 24646 accept-ranges: bytes age: 40997 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 vary: Accept-Encoding, User-Agent x-backend: local x-cache: cached x-cache-hit: HIT x-cacheable: YES:Forced x-content-type-options: nosniff x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains |
Domain Name: PROJENX.COM Registry Domain ID: 2633499597_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-01-11T23:25:40Z Creation Date: 2021-08-12T20:40:57Z Registry Expiry Date: 2023-08-12T20:40:57Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS57.DOMAINCONTROL.COM Name Server: NS58.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-03-08T09:38:41Z <<< |